| Orbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging BS Purohit, MI Vargas, A Ailianou, L Merlini, PA Poletti, A Platon, ... Insights into imaging 7, 43-68, 2016 | 138 | 2016 |
| Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV A Varoquaux, O Rager, KO Lovblad, K Masterson, P Dulguerov, O Ratib, ... European journal of nuclear medicine and molecular imaging 40, 842-852, 2013 | 116 | 2013 |
| Detection and quantification of focal uptake in head and neck tumours: 18F-FDG PET/MR versus PET/CT A Varoquaux, O Rager, A Poncet, BMA Delattre, O Ratib, CD Becker, ... European journal of nuclear medicine and molecular imaging 41, 462-475, 2014 | 107 | 2014 |
| Diffusion-weighted and PET/MR imaging after radiation therapy for malignant head and neck tumors A Varoquaux, O Rager, P Dulguerov, K Burkhardt, A Ailianou, M Becker Radiographics 35 (5), 1502-1527, 2015 | 68 | 2015 |
| Local recurrence of squamous cell carcinoma of the head and neck after radio (chemo) therapy: diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences M Becker, AD Varoquaux, C Combescure, O Rager, M Pusztaszeri, ... European radiology 28, 651-663, 2018 | 66 | 2018 |
| Whole-body SPECT/CT versus planar bone scan with targeted SPECT/CT for metastatic workup O Rager, R Nkoulou, N Exquis, V Garibotto, C Tabouret-Viaud, H Zaidi, ... BioMed research international 2017, 2017 | 63 | 2017 |
| Clinical assessment of MR-guided 3-class and 4-class attenuation correction in PET/MR H Arabi, O Rager, A Alem, A Varoquaux, M Becker, H Zaidi Molecular imaging and biology 17, 264-276, 2015 | 63 | 2015 |
| Potential of hybrid 18F-fluorocholine PET/MRI for prostate cancer imaging T De Perrot, O Rager, M Scheffler, M Lord, M Pusztaszeri, C Iselin, ... European journal of nuclear medicine and molecular imaging 41, 1744-1755, 2014 | 57 | 2014 |
| First imaging results of an intraindividual comparison of 11C-acetate and 18F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or … F Buchegger, V Garibotto, T Zilli, L Allainmat, S Jorcano, H Vees, O Rager, ... European journal of nuclear medicine and molecular imaging 41, 68-78, 2014 | 56 | 2014 |
| SPECT/CT in differentiation of pseudarthrosis from other causes of back pain in lumbar spinal fusion: report on 10 consecutive cases O Rager, K Schaller, M Payer, D Tchernin, O Ratib, E Tessitore Clinical nuclear medicine 37 (4), 339-343, 2012 | 55 | 2012 |
| PET/MR in breast cancer C Tabouret-Viaud, D Botsikas, BMA Delattre, I Mainta, G Amzalag, ... Seminars in nuclear medicine 45 (4), 304-321, 2015 | 48 | 2015 |
| Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as … I Valenta, A Quercioli, G Vincenti, R Nkoulou, S Dewarrat, O Rager, ... Journal of Nuclear Cardiology 17 (6), 1023-1033, 2010 | 29 | 2010 |
| Radioisotope imaging for discriminating benign from malignant cytologically indeterminate thyroid nodules O Rager, P Radojewski, RA Dumont, G Treglia, L Giovanella, MA Walter Gland surgery 8 (Suppl 2), S118, 2019 | 27 | 2019 |
| Accuracy of whole-body HDP SPECT/CT, FDG PET/CT, and their combination for detecting bone metastases in breast cancer: an intra-personal comparison O Rager, SA Lee-Felker, C Tabouret-Viaud, ER Felker, A Poncet, ... American journal of nuclear medicine and molecular imaging 8 (3), 159, 2018 | 24 | 2018 |
| Target definition in salvage radiotherapy for recurrent prostate cancer: the role of advanced molecular imaging G Amzalag, O Rager, C Tabouret-Viaud, M Wissmeyer, E Sfakianaki, ... Frontiers in oncology 6, 73, 2016 | 24 | 2016 |
| Long-term results of a comparative PET/CT and PET/MRI study of 11C-acetate and 18F-fluorocholine for restaging of early recurrent prostate cancer G Lamanna, C Tabouret-Viaud, O Rager, S Jorcano, HJ Vees, Y Seimbille, ... Clinical Nuclear Medicine 42 (5), e242-e246, 2017 | 20 | 2017 |
| Whole body PET-MRI scanner: first experience in oncology O Ratib, M Becker, JP Vallée, P Loubeyre, M Wissmeyer, JP Willi, ... J Nucl Med 51 (Suppl 2), 165, 2010 | 20 | 2010 |
| Low dose pioglitazone does not affect bone formation and resorption markers or bone mineral density in streptozocin-induced diabetic rats E Tsirella, T Mavrakanas, O Rager, S Tsartsalis, K Kallaras, B Kokkas, ... Journal of Physiology and Pharmacology 63 (2), 201, 2012 | 18 | 2012 |
| Downstream indication to revascularization following hybrid cardiac PET/MRI: preliminary results J Priamo, D Adamopoulos, O Rager, A Frei, S Noble, D Carballo, O Ratib, ... Nuclear medicine communications 38 (6), 515-522, 2017 | 16 | 2017 |
| Spinal uptake mimicking metastasis in SPECT/CT bone scan in a patient with superior vena cava obstruction O Rager, R Nkoulou, V Garibotto, S Boudabbous, D Arditi Clinical nuclear medicine 38 (11), 908-909, 2013 | 16 | 2013 |
Habib Zaidi, FIEEE, FAIMBE, FAAPM,...Full Professor, Geneva University Hospital and University of GenevaVerified email at unige.ch
